Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions

The interest in tumor-infiltrating lymphocytes (TILs) as a prognostic biomarker in breast cancer has grown in recent years. Biomarkers must undergo comprehensive evaluation in terms of analytical validity, clinical validity and clinical utility before they can be accepted as part of clinical practic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wein, Lironne, Savas, Peter, Luen, Stephen J., Virassamy, Balaji, Salgado, Roberto, Loi, Sherene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540942/
https://www.ncbi.nlm.nih.gov/pubmed/28824872
http://dx.doi.org/10.3389/fonc.2017.00156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540942/
https://www.ncbi.nlm.nih.gov/pubmed/28824872
http://dx.doi.org/10.3389/fonc.2017.00156

Ejemplares similares